| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO
PL PT RO SE SI SK TR |
| (30) |
Priority: |
31.03.2008 JP 2008093292
|
| (43) |
Date of publication of application: |
|
05.01.2011 Bulletin 2011/01 |
| (73) |
Proprietor: tella Inc. |
|
Shinjuku-ku
Tokyo 160-0023 (JP) |
|
| (72) |
Inventor: |
|
- NISHIMURA, Takashi
Hokkaido 060-0808 (JP)
|
| (74) |
Representative: Wasner, Marita |
|
Niizuma Wasner GmbH
Postfach 273
4125 Riehen 1
4125 Riehen 1 (CH) |
| (56) |
References cited: :
WO-A1-2007/036638
JP-A- 2006 230 269
JP-T- 2006 517 529
|
WO-A2-2004/099389
JP-T- 2005 537 800
US-A1- 2007 104 689
|
|
| |
|
|
- MOLA G ET AL: "Exonization of Alu-generated Splice Variants in the Survivin Gene of
Human and Non-human Primates", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 366,
no. 4, 2 March 2007 (2007-03-02) , pages 1055-1063, XP025769377, ISSN: 0022-2836,
DOI: DOI:10.1016/J.JMB.2006.11.089 [retrieved on 2007-02-03]
- CALDAS HUGO ET AL: "Survivin 2[alpha]: a novel Survivin splice variant expressed in
human malignancies", MOLECULAR CANCER, BIOMED CENTRAL, LONDON, GB, vol. 4, no. 1,
2 March 2005 (2005-03-02), page 11, XP021008232, ISSN: 1476-4598, DOI: DOI:10.1186/1476-4598-4-11
- WANG, X.F. ET AL.: 'Comprehensive analysis of HLA-DR- and HLA-DP4-restricted CD4+
T cell response specific for the tumor-shared antigen surviving in healthy donors
and cancer patients' J. IMMUNOL. vol. 181, no. 1, July 2008, pages 431 - 439, XP008136341
- 'Annual Meeting of the Japan Cancer Association, (Sep. 2008)', vol. 67TH, 2008 article
OHKURI, T. ET AL.: 'Identification of survivin helper epitopes and survivin-specific
Th1 cells applicable to human Th1 cell therapy', page 293
- PIESCHE, M. ET AL.: 'Identification of a promiscuous HLA DR-restricted T-cell epitope
derived from the inhibitor of apoptosis protein survivin' HUMAN IMMUNOL. vol. 68,
2007, pages 572 - 576, XP022208511
|
|
